| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |